CN Patent

CN114133378B — 一种盐酸尼洛替尼共晶及其制备方法

Assigned to Sichuan Qingmu Pharmaceutical Co ltd · Expires 2023-08-15 · 3y expired

What this patent protects

本申请涉及药物晶型领域，具体涉及一种盐酸尼洛替尼L‑酒石酸共晶及其制备方法。本发明所述盐酸尼洛替尼L‑酒石酸共晶溶解度大，生物利用度高，稳定性好且制备方法简单，环保，重复性好，适合大规模工业化生产。

USPTO Abstract

本申请涉及药物晶型领域，具体涉及一种盐酸尼洛替尼L‑酒石酸共晶及其制备方法。本发明所述盐酸尼洛替尼L‑酒石酸共晶溶解度大，生物利用度高，稳定性好且制备方法简单，环保，重复性好，适合大规模工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN114133378B
Jurisdiction
CN
Classification
—
Expires
2023-08-15
Drug substance claim
No
Drug product claim
No
Assignee
Sichuan Qingmu Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.